Company / PP&E (Net)
PUMA BIOTECHNOLOGY, INC. PP&E (Net) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$187.0K
FY2025
5-year range
$187.0K / $1.8M
FY2021-FY2025
Trend
-63.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 8 consecutive years, from $4M in FY2017 to $187,000 in FY2025.
Based on SEC 10-K filings.
$187,000 in FY2025 with a 5-year CAGR of -40.4%.
Declined from $855,000 to $187,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -45.4%
- 5-Year CAGR
- -40.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s pp&e (net) has declined for 8 consecutive years.
- 5-year CAGR of -40.4%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 63.7% year-over-year.
- Peak pp&e (net) was recorded in FY2017.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $187.0K | -63.7% |
| FY2024 | $515.0K | -39.8% |
| FY2023 | $855.0K | -25.4% |
| FY2022 | $1.1M | -34.7% |
| FY2021 | $1.8M | -29.2% |
| FY2020 | $2.5M | -24.9% |
| FY2019 | $3.3M | -16.6% |
| FY2018 | $4.0M | -11.3% |
| FY2017 | $4.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026